This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
WALTHAM, Mass., March 13, 2014 (GLOBE NEWSWIRE) -- BG Medicine, Inc. (Nasdaq:BGMD) today announced that the company will host a conference call and webcast on Thursday, March 20, 2014 at 8:30 a.m. Eastern Time to discuss its fiscal year 2013 financial results before the market opens.
Conference Call Details
The conference call may be accessed by dialing (877) 845-1016 from the U.S. and Canada, or (708) 290-1155 from international locations. The conference call will also be available via the Internet at
Listeners are encouraged to login at least 15 minutes prior to the start of the scheduled presentation to register, download and install any necessary audio software.
To access the live and subsequently archived webcast of the conference call, go to the Investor Relations section of the company's website at
www.bg-medicine.com . Please connect to the website at least 15 minutes prior to the call to download and install any necessary audio software.
About BG Medicine
BG Medicine, Inc. (Nasdaq:BGMD), the developer of the BGM Galectin-3® Test, is focused on the development and delivery of diagnostic solutions to aid in the clinical management of heart failure and related disorders. For additional information about BG Medicine, heart failure and galectin-3 testing, please visit
The BG Medicine, Inc. logo is available for download
CONTACT: Steve Hall
EVP & Chief Financial Officer